참고문헌
- Ali-El-Dein B, Sarhan O, Hinev A, et al (2003). Superficial bladder tumours: Analysis of prognostic factors and construction of a predictive index. BJU Int, 92, 393-9. https://doi.org/10.1046/j.1464-410X.2003.04360.x
- Badar F, Sattar A, Meerza F, Irfan N, Siddiqui N (2009). Carcinoma of the urinary bladder in a tertiary care setting in a developing country. Asian Pac J Cancer Prev, 10, 449-2
- Brausi M, Collette L, Kurth K, et al (2002). EORTC Genito-Urinary Tract Cancer Collaborative Group: Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta\T1 transitional Cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur Urol, 41, 523-1. https://doi.org/10.1016/S0302-2838(02)00068-4
- Ghafouri-Fard S, Nekoohesh L, Motevaseli E (2014). Bladder cancer biomarkers: review and update. Asian Pac J Cancer Prev, 15, 2395-3. https://doi.org/10.7314/APJCP.2014.15.6.2395
- Hall CM, Chang SS, Dalbagni G, et al (2007). Guideline for the management of nonmuscle invasive bladder cancer (Stages Ta, T1, and Tis): 2007 Update from the American Urological Association Education and Research, Inc J Urol, 178, 2314-0 https://doi.org/10.1016/j.juro.2007.09.003
- Heney NM, Nocks BN, Daly JJ, et al (1982). Ta and T1 bladder cancer: location, recurrence and progression. Br J Urol, 52, 152-7
- Herr HW (2000). Tumor progression and survival of patients with high grade, noninvasive papillary (TaG3) bladder tumors: 15-year outcome. J Urol, 163, 60-1 https://doi.org/10.1016/S0022-5347(05)67972-4
- Jemal A, Bray F, Center MM, et al. Global cancer statistics (2011). CA Cancer J Clin, 61, 69-0. https://doi.org/10.3322/caac.20107
- Millan-Rodriguez F, Chechile-Toniolo G, Salvador-Bayarri J, Palou J, Vicente-Rodriguez J. Multivariate analysis of the prognostic factors of primary superficial bladder cancer (2000). J Urol, 163, 73-8. https://doi.org/10.1016/S0022-5347(05)67975-X
- Oosterlinck W. Guidelines on diagnosis and treatment of superficial bladder cancer (2004). Minerva Urol Nephrol, 56, 65-2.
- Pelucchi C, Bosetti C, Negri E, Malvezzi M, La Vecchia C (2006). Mechanisms of disease: the epidemiology of bladder cancer. Nat Clin Pract Urol, 3, 327-0. https://doi.org/10.1038/ncpuro0510
- Salehi A, Khezri A, Malekmakan L, Aminsharifi A (2011). Epidemiologic status of bladder cancer in Shiraz, Southern Iran. Asian Pac J Cancer Prev, 12, 1323-7.
- Shakhssalim N, Hosseini SY, Basiri A, et al (2010). Prominent bladder cancer risk factors in Iran. Asian Pacific J Cancer Prev, 11, 601-6.
- Supit W, Mochtar CA, Sugiono M, Umbas R (2011). Survival of patients with transitional cell carcinoma of the urinary bladder in Indonesia: A single institution review. Asian Pac J Cancer Prev, 12, 549-3
- Sylvester RJ, Van der Meijden AP, Oosterlinck W, et al (2006). Predicting recurrence and progression in individual patients with stage Ta, T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol, 3, 466-5.
- Wu X, Ros MM, Gu J, Kiemeney L (2008). Epidemiology and genetic susceptibility to bladder cancer. BJU Int, 102, 1207-5. https://doi.org/10.1111/j.1464-410X.2008.07961.x
- Yaris F, Dikici MF, Sabuncu HH, Yaris E (2006). A case-control study on the etiology of urinary bladder cancer in Istanbul, Turkey. Asian Pac J Cancer Prev, 7, 591-4.
- Yavari P, Sadrolhefazi B, Mohagheghi MA, Mehrazin R (2009). A descriptive retrospective study of bladder cancer at a hospital in Iran (1973-2003). Asian Pac J Cancer Prev, 10, 681-4.
- Zeegers MP, Tan FE, Dorant E, van der Brandt PA (2000). The impact of characteristics of cigarette smoking on urinary tract cancer risk: A meta-analysis of epidemiologic studies. Cancer, 89, 630-9. https://doi.org/10.1002/1097-0142(20000801)89:3<630::AID-CNCR19>3.0.CO;2-Q
피인용 문헌
- Immunohistochemical Differentiation between Urothelial Papillomas and Papillary Neoplasms of Low Malignant Potential of the Urinary Bladder vol.17, pp.4, 2016, https://doi.org/10.7314/APJCP.2016.17.4.1769